Literature DB >> 14990880

Study of the analgesic efficacy of Dexketoprofen Trometamol 25mg. vs. Ibuprofen 600mg. after their administration in patients subjected to oral surgery.

Esther Jiménez-Martínez1, Carmen Gasco-García, Juan José Arrieta-Blanco, Javier Gomez del Torno, Begoña Bartolome Villar.   

Abstract

OBJECTIVES: Compare the analgesic efficacy of two nonsteroidal anti-inflammatory drugs (NSAIDs) belonging to the family of propionic acids after oral surgery in order to assess which one is most effective with the minimum side effects and lowest dose. Normally, the pain after oral surgery is considered as moderate-intense and NSAIDs are the first choice when treating post-surgical dental pain. As we know, the great problem of these drugs is found in their undesirable effects. The enantiomer-S(+) component is known to be related with analgesia and need for lower dose of these drugs.
DESIGN: The patients are given questionnaires with pain assessment tables and different observations are made: postsurgical pain, pain in the first hour after administration of the analgesic, inflammation, bleeding, hematoma, etc. We assess the effect of the different drugs used in the study based on the efficacy-time coordinates as well as the anti-inflammatory effect and their side effects.
RESULTS: It is verified that there is moderate pain after oral surgery and the drugs used are effective in the doses and intervals indicated. During the first hour after taking the analgesic, those patients treated with Dexketoprofen Trometamol (DKT) presented less pain compared to those who were treated with Ibuprofen (IBU). It is verified that there is inflammation in most of the interventions, the extractions of the semi-impacted third molars (SITM) present greater bleeding on the first day and the extractions of impacted third molars (ITM) present more bleeding on the third day. These last two interventions (ITM) also present hematoma.
CONCLUSIONS: We demonstrate the greater analgesic efficacy of Dexketoprofen Trometamol in the first hour after the oral surgical intervention and its greater anti-inflammatory effect.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990880

Source DB:  PubMed          Journal:  Med Oral        ISSN: 1137-2834


  6 in total

Review 1.  Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults.

Authors:  Jodie Barden; Sheena Derry; Henry J McQuay; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2009-10-07

2.  Systematic Review and Meta-Analysis of the Association Between Non-Steroidal Anti-Inflammatory Drugs and Operative Bleeding in the Perioperative Period.

Authors:  Tasce Bongiovanni; Elizabeth Lancaster; Yeranuí Ledesma; Evans Whitaker; Michael A Steinman; Isabel Elaine Allen; Andrew Auerbach; Elizabeth Wick
Journal:  J Am Coll Surg       Date:  2021-01-27       Impact factor: 6.532

3.  Effect of low-dose dexketoprofen trometamol and paracetamol on postoperative complications after impacted third molar surgery on healthy volunteers: A pilot study.

Authors:  Cennet-Neslihan Eroglu; Ercan Durmus; Demet Kiresi
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2014-11-01

4.  Comparison of intravenous dexketoprofen and dipyrone in acute renal colic.

Authors:  Juan Sánchez-Carpena; Fermín Domínguez-Hervella; Ignasi García; Emili Gene; Rosendo Bugarín; Angel Martín; Santiago Tomás-Vecina; Dolors García; José Antonio Serrano; Antonio Roman; Miguel Mariné; María Luisa Mosteiro
Journal:  Eur J Clin Pharmacol       Date:  2007-06-15       Impact factor: 3.064

Review 5.  Systematic review of dexketoprofen in acute and chronic pain.

Authors:  R Andrew Moore; Jodie Barden
Journal:  BMC Clin Pharmacol       Date:  2008-10-31

6.  Comparison of the efficacy of low doses of methylprednisolone, acetaminophen, and dexketoprofen trometamol on the swelling developed after the removal of impacted third molar.

Authors:  Cennet-Neslihan Eroglu; Hanife Ataoglu; Gulsun Yildirim; Demet Kiresi
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-09-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.